Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepato-Renal Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05875948
What this trial is testing

Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome

Who this might be right for
Hepatorenal SyndromeAcute Kidney Injury
River 2 Renal Corp. 95
Post-approval studies (Phase 4)UnknownNCT01530711
What this trial is testing

Treatment of Hepatorenal Syndrome With Terlipressin Infusion Adjusted to Hemodynamic Response

Who this might be right for
CirrhosisHepatorenal Syndrome Type I
Pere Gines 40
Large-scale testing (Phase 3)Study completedNCT02770716
What this trial is testing

Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1

Who this might be right for
Hepatorenal Syndrome
Mallinckrodt 300
Large-scale testing (Phase 3)Ended earlyNCT00742339
What this trial is testing

Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome

Who this might be right for
CirrhosisHepatorenal Syndrome
University of Padova 49
Testing effectiveness (Phase 2)WithdrawnNCT04048707
What this trial is testing

Angiotensin 2 for Hepatorenal Syndrome

Who this might be right for
Hepatorenal SyndromeCirrhosisKidney Failure, Acute
University of California, Los Angeles
Not applicableEnded earlyNCT00734136
What this trial is testing

Role Of Angiogenic Factors In The Development Of Hepatorenal Syndrome

Who this might be right for
Hepatorenal SyndromeRenal FailureLiver Diseases
Lahey Clinic 100
Testing effectiveness (Phase 2)Study completedNCT01133795
What this trial is testing

Midodrine and Albumin for Cirrhotic Patients With Functional Renal Impairment

Who this might be right for
CirrhosisRenal Failure
Hospital Clinic of Barcelona 7
Testing effectiveness (Phase 2)Study completedNCT01373606
What this trial is testing

Terlipressin in Patients With Hepatorenal Syndrome Type 1

Who this might be right for
Hepatorenal Syndrome Type 1
Ferring Pharmaceuticals 8
Not applicableWithdrawnNCT01649037
What this trial is testing

To Compare the Efficacy of Nor Adrenaline and Terlipressin vs Step up Terlipressin Therapy in Hepatorenal Syndrome

Who this might be right for
Hepatorenal Syndrome
Institute of Liver and Biliary Sciences, India
Post-approval studies (Phase 4)Temporarily pausedNCT00287664
What this trial is testing

Treatment of Hepatorenal Syndrome With Terlipressin Plus Albumin vs Albumin

Who this might be right for
CirrhosisHepatorenal Syndrome
Hospital Clinic of Barcelona 100
Testing effectiveness (Phase 2)WithdrawnNCT01587222
What this trial is testing

Midodrine, Octreotide and Albumin: Impact on Renal Function of Patients With Liver Cirrhosis and Renal Failure

Who this might be right for
FibrosisRenal FailureHepatorenal Syndrome
Anna Cruceta
Large-scale testing (Phase 3)Study completedNCT01143246
What this trial is testing

A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin

Who this might be right for
Hepatorenal Syndrome
Mallinckrodt 196
Not applicableNot Yet RecruitingNCT07084688
What this trial is testing

Swiss Cardiovascular-Kidney-Liver-Metabolic (CKLM) Registry

Who this might be right for
Cradiovascular-kidney-liver-metabolic (CKLM) SyndromeCardiovascular-kidney-metabolic Syndrome
University Hospital, Basel, Switzerland 1,500
Not applicableStudy completedNCT07460908
What this trial is testing

Comparison of Terlipressin Versus Octreotide in Patients With Hepatorenal Syndrome

Who this might be right for
Hepatorenal Syndrome
Lahore General Hospital 60
Not applicableLooking for participantsNCT06095440
What this trial is testing

A Retrospective Analysis of Outcomes in Patients With Hepatorenal Syndrome at Methodist Dallas Medical Center

Who this might be right for
Hepatorenal Syndrome
Methodist Health System 500
Not applicableStudy completedNCT04416282
What this trial is testing

Efficacy of Early Terlipressin Plus Albumin Therapy in Comparison to Standard Treatment for HRS-AKI in Acute-on-chronic Liver Failure.

Who this might be right for
Acute-On-Chronic Liver FailureHepatorenal SyndromeAcute Kidney Injury
Institute of Liver and Biliary Sciences, India 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT06256432
What this trial is testing

Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome

Who this might be right for
Hepatorenal SyndromeLiver CirrhosisAcute Kidney Injury+1 more
Noorik Biopharmaceuticals AG 54
Not applicableStudy completedNCT02573727
What this trial is testing

To Compare the Response Rate of Noradrenaline vs. Terlipressin in Hepatorenal Syndrome in Patients With Acute on Chronic Liver Failure

Who this might be right for
Acute on Chronic Liver Failure
Institute of Liver and Biliary Sciences, India 120
Not applicableLooking for participantsNCT02434445
What this trial is testing

Use of Novel Plasma and Urinary Biomarkers to Predict the Development of Hepatorenal Syndrome in Cirrhotic Patients

Who this might be right for
Hepatorenal Syndrome
The University of Hong Kong 100
Not applicableUnknownNCT02049125
What this trial is testing

Study of Accuracy of NGAL, a Renal Injury Biomarker, in Patients With Cirrhosis

Who this might be right for
Acute Kidney InjuryHepatorenal Syndrome
University of Sao Paulo 300
Next Page